Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-031752
Filing Date
2021-12-16
Accepted
2021-12-16 18:00:12
Documents
1
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4027
  Complete submission text file 0001493152-21-031752.txt   5408
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 222 THIRD STREET SUITE 2300 CAMBRIDGE MA 02142
Business Address
Eldridge George A (Reporting) CIK: 0001413006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 211498930

Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations